A tighter core stabilizes SARS-CoV-2 spike protein in new emergent variants
Phys.org· 12 hours agoJust as a tight core is a component of good physical fitness for humans, helping to stabilize our bodies, mutations that tightened the core of the SARS-CoV
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered...
Nature· 5 days agoSARS-CoV-2 vaccines prevent severe disease but are less efficient in averting infection and transmission of variant strains, making it ...
Study: Long COVID could involve factors other than SARS-CoV-2 infection
Center for Infectious Disease Research and Policy· 7 hours agoThe authors said a range of factors--biological, psychological, or social--might trigger and maintain long COVID symptoms.
A Regulator Looks Back On What We Learned From Accelerated SARS-CoV-2 Neutralizing mAbs Development
BioresearchOnline· 3 days agoThe end of the COVID-19 public health emergency (PHE) in the United States appears to be on the...
Team designs molecule to disrupt SARS-CoV-2 infection
Medical Xpress· 4 days agoA team of scientists led by the Department of Energy's Oak Ridge National Laboratory designed a...
Study identifies SARS-CoV-2 variants with antiviral resistance mutations
Center for Infectious Disease Research and Policy· 19 hours agoThe variants predate the use of the drugs, appeared independently in multiple world regions, and are capable of spreading.
Why The Latest COVID Variant Has The World Health Organization Concerned
MSN News· 2 days agoMany people now consider the pandemic a thing of the past. However, officials continue to monitor...
Nanobiosensor developed for detecting SARS-CoV-2
Phys.org· 5 days agoInfection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies...
Discovery of drug candidate that neutralizes SARS-CoV-2 could reduce length of infection upon...
Phys.org· 4 days agoUnlike Pfizer's antiviral treatment Paxlovid, which is only useful during the first three days of showing symptoms, this possible new medication could reduce the course of the virus upon exposure ...
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2...
Nature· 2 days agoRecombinant protein-based SARS-CoV-2 vaccines are needed to fill the vaccine equity gap. Because protein-subunit based vaccines are easier ...
Yahoo Web Search
Trending Now
